Cleo Diagnostics Confirms Efficacy of Ovarian Cancer Test From Validation Study; Shares Surge 21%
Cleo Diagnostics Confirms Efficacy of Ovarian Cancer Test From Validation Study; Shares Surge 21%
克萊奧診斷通過驗證研究證實了卵巢癌檢測的功效；股價飆升21％
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊